CD8A and neoplasm: Furthermore, regulatory factor X5 (RFX5), a key regulator of MHC class II molecule expression [29], connects adaptive immunity through non-classical antigen presentation functions, and its heightened activity in CD8+ TEM cells may play a pivotal role in orchestrating their anti-tumor responses.